Kurt D Christensen, Ph.D.
Assistant Professor of Population Medicine
Harvard Pilgrim Healthcare
Harvard Pilgrim Health Care Institute
Landmark Center, Department of Population Medicine
401 Park Dr
Boston MA 02215
A future where genomic information is readily available is rapidly approaching. Whether this information improves public health by improving patient care and empowering prevention, or whether it diminishes public health by motivating unnecessary follow-up testing and screening is unclear. I use my training in health economics, biochemistry, public health, and health behavior and health education to address these issues by focusing on three interrelated questions: 1) How do patients and physicians respond, behaviorally and psychologically, to information generated from emerging genomic technologies like whole genome sequencing? 2) What is the healthcare service and economic impact of integrating genomics into the everyday practice of medicine? 3) How can programs be improved to maximize the benefits and minimize the harms of genomic testing? The answers to these questions are essential as healthcare providers and policymakers make decisions about how to offer and support new genomic services.
The research activities and funding listed below are automatically derived from
NIH ExPORTER and other sources, which might result in incorrect or missing items.
to make corrections and additions.
(GREEN, ROBERT C.)
Jul 1, 2019 - Jun 30, 2023
Return of Genomic Results and Estimating Penetrance in Population-Based Cohorts
Role Description: The overall goal of the proposed research is to develop and implement a genomic
return of result process in the Framingham Heart Study and Jackson Heart Study
cohorts and explore associated medical, behavioral and economic outcomes. We will also develop ways to automate and streamline genomic variant interpretation at scale, and develop analyses to aid assessment of penetrance.
(CHRISTENSEN, KURT DEREK)
Feb 12, 2019 - Dec 31, 2022
Medical/Economic ImpactT and Behavioral Responses to Integrating the Sanford ChipS (METRICS) Study
Role Description: This goal of this research agreement is to summarize the impact of integrating
pharmacogenetic and disease predisposition information into patient care within primary
care settings, including the effect on clinician preparedness, provider and patient
behaviors, medical and economic outcomes, and familial outcomes.
Role: Principal Investigators
(GREEN, ROBERT C.)
Sep 21, 2018 - Jun 30, 2021
Experiences and Outcomes in Early Adopters of Predispositional Sequencing
Role Description: The objective of this research is to aggregate data from, and assess the value of, personal predispositional genome sequencing among participants in present day projects focused on sequencing apparently healthy individuals.
(WU, ANN CHEN)
Sep 11, 2017 - May 31, 2022
Precision Medicine Policy and Treatment (PreEMPT) Model
Role Description: This goal of this grant is to develop a detailed computer microsimulation model capable of
simulating the clinical benefits, potential risks, and cost consequences associated with the
integration of different genomic sequencing screening strategies into clinical care.
(GREEN, ROBERT C.)
Jan 1, 2017 - Dec 31, 2019
MilSeq: Enabling Personalized Medicine through Exome Sequencing in the U.S. Air Force
Role Description: The goal of this project is to test a pilot protocol for integrating genomic sequencing into
the care of active duty airmen.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.